Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesPsychophysiological disorders among buprenorphine patients
International Journal of Psychiatry in Clinical Practice, 09/02/09
Sansone RA et al. – The authors examined the prevalence of 14 psychophysiological disorders among 114 opioid–dependent individuals as well as the relationship between these disorders and borderline personality. In the aftermath of analyses, only migraine headaches and chronic pain demonstrated relatively high frequency rates in this sample. Only migraine headaches showed a significant relationship with the diagnosis of borderline personality symptoms. In conclusion, in an opioid–dependent population, the prevalence of psychophysiological disorders appears to be rather unremarkable.
Today in Mood Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder
Canadian Journal of Psychiatry, 11/16/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Clinical trials support new algorithm for treating pediatric bipolar mania
Current Psychiatry, 11/16/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09
Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder
Canadian Journal of Psychiatry, 11/16/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Today in Personality Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
Impulsivity, personality and bipolar disorder
European Psychiatry , 11/06/09
Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder
International Clinical Psychopharmacology, 10/23/09
Today in Substance Abuse...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
Drug use and addiction: evolutionary perspective
Australian and New Zealand Journal of Psychiatry, 11/04/09
Tobacco as a Substance of Abuse
Pediatrics, 11/05/09
Sponsor
Article Search
Sponsor